Life to appeal Federal Court decision

By Dylan Bushell-Embling
Tuesday, 29 July, 2008

Life Therapeutics [ASX: LFE] today announced its decision to appeal the recent Federal Court decision preventing it from selling shares to Aegis Partners.

The decision was handed down as the result of a lawsuit lodged by Life Therapeutics shareholder Bell IXL Investments.

Bell has been trying to mount a takeover of Life and has demanded the resignation of its board of directors.

But Life financier and customer Octapharma has been urging against the decision to change directors.

Octapharma is itself involved in a dispute with Life, claiming Life has under-delivered product to the tune of US$11 million.

As a result of the appeal, the shareholder meeting planned to discuss the company's future directorial structure may be postponed past the planned August 7 date.

Related News

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Maternal cannabis use puts kids at risk of behavioural problems

Children exposed to their mother's cannabis use during pregnancy and after birth are three...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd